<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical use of St. John's wort</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical use of St. John's wort</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical use of St. John's wort</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert B Saper, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joann G Elmore, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>St. John's wort (<em>Hypericum perforatum</em>) is a five-petal yellow flower  (<a class="graphic graphic_picture graphicRef59164" href="/z/d/graphic/59164.html" rel="external">picture 1</a>) that has been used medicinally since antiquity [<a href="#rid1">1</a>]. It was commonly referred to as "Fuga daemonum" (the devil's scourge) since it was used to protect against demonic possession and "evil spirits" [<a href="#rid2">2</a>]. One of the earliest references to the name St. John's wort is noted in a Gaelic legend from the sixth century where the missionary St. Columba carried a piece of St. John's wort because of his high regard for St. John [<a href="#rid1">1</a>]. It is believed that the name may have been derived from the fact that the flowers bloom around June 24<sup>th</sup>, the birthday of St. John the Baptist. Wort represents the old English term for plant.</p><p class="headingAnchor" id="H1831320875"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>St. John's wort has been utilized primarily for its possible antidepressant activity but also for its purported antiinflammatory and wound healing properties [<a href="#rid3">3</a>]. In 2002, St. John's wort was the sixth most popular natural product in the United States, used by 2.2 percent of American adults [<a href="#rid4">4</a>]. In 2007 and 2012, the National Health Interview Survey found large decreases in St. John's wort use by adults in the United States, when it was not among the 20 most commonly used dietary supplements [<a href="#rid5">5</a>]. This decrease may reflect the public's response to interim news reports of negative clinical trials [<a href="#rid6">6-8</a>] and potentially harmful interactions with prescription drugs [<a href="#rid9">9-22</a>].</p><p class="headingAnchor" id="H2"><span class="h1">PROPOSED MECHANISMS OF ACTION</span><span class="headingEndMark"> — </span>A number of compounds isolated from St. John's wort possess pharmacologic activity, including naphthodianthrones (hypericin, pseudohypericin, protohypericin, protopseudohypericin, and cyclopseudohypericin), flavonoids (quercetin, rutin, and luteolin), hyperforin, several amino acids, and tannins [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Neuropharmacology</span><span class="headingEndMark"> — </span>The majority of in vitro studies of St. John's wort have attempted to define its neuropharmacology. Hyperforin and hypericin have been studied most extensively. Although hypericin was originally thought to be the major active component for St. John's wort in depression, it is now believed that hyperforin and related compounds are mostly responsible for St. John's wort's effect on mood.</p><p>In animal studies, hyperforin extracts have been shown to modulate neurotransmitter levels including serotonin, norepinephrine, and dopamine [<a href="#rid24">24,25</a>]. This may be in part from inhibition of neurotransmitter uptake. Other studies have found that hypericum extract possesses a weak catechol-O-methyl transferase activity [<a href="#rid26">26</a>], and the hypericum extract LI 160 causes 50 percent inhibition of serotonin uptake by rat synaptosomes [<a href="#rid27">27</a>]. The latter occurred only at relatively high concentrations.</p><p>In in vitro studies, St. John's wort standardized extract LI 160 is capable of decreasing cell surface 5-hydroxytryptamine (5-HT) receptors, and it also suppresses the release of interleukin 6 (IL-6), which induces the release of corticotropin-releasing hormone (implicated in depression) [<a href="#rid28">28,29</a>]. St. John's wort extracts also have been shown to inhibit in vitro binding at the muscarinic cholinergic receptor (mAchR), 5-HT, and norepinephrine uptake sites, but only at high concentrations [<a href="#rid30">30</a>]. These neuropharmacologic changes, however, have not been demonstrated in human studies.</p><p class="headingAnchor" id="H4"><span class="h2">In vitro antiviral and antibacterial activity</span><span class="headingEndMark"> — </span>St. John’s wort has in vitro antiviral activity against murine cytomegalovirus, parainfluenza 3 virus, Sindbis virus, vesicular stomatitis virus, and equine infectious anemia virus [<a href="#rid31">31-33</a>].Similarly, despite hypericin demonstrating in vitro antibacterial activity against gram-positive and gram-negative organisms [<a href="#rid34">34</a>], including methicillin-resistant and non-resistant <em>Staphylococcus aureus</em> [<a href="#rid35">35</a>], robust data supporting its efficacy against bacterial infections in humans are lacking.</p><p class="headingAnchor" id="H6"><span class="h1">LIMITED EVIDENCE OF EFFICACY FOR MOST CONDITIONS</span><span class="headingEndMark"> — </span>Patients considering the use of St. John's wort should be counseled and cautioned regarding the limited evidence of efficacy, the variability in commercially available products, the lack of regulation in St. John's wort products in the United States, and the potential for herb-drug interactions.</p><p class="headingAnchor" id="H7"><span class="h2">Depression</span><span class="headingEndMark"> — </span>St. John's wort is widely used in the management of depression. However, given the inconsistent evidence for efficacy and the lack of regulated standardized herbal products, we suggest <strong>not</strong> treating depression with St. John's wort. In addition, there are also multiple interactions between St. John's wort and many commonly used medications. (See  <a class="medical medical_review" href="/z/d/html/90155.html" rel="external">"Unipolar depression in adults: Investigational and nonstandard treatment", section on 'Omega-3 fatty acids'</a> and <a class="local">'Drug interactions'</a> below.)</p><p>In a 2008 meta-analysis of 29 trials (23 Europe, 4 United Sates, 1 Canada, 1 Brazil) including 5500 adults with depression, standardized extracts of St. John's wort were more effective than placebo and comparable in efficacy to standard antidepressants for the treatment of mild to moderate depression at 12 weeks [<a href="#rid36">36</a>]. However, these results were not observed in the United States trials [<a href="#rid6">6-8,37</a>]. Reasons for this discrepancy may include differences in enrolled patients, lack of concealment of treatment allocation, or variations in the individual preparations studied.</p><p class="headingAnchor" id="H8"><span class="h2">Somatic symptom disorders</span><span class="headingEndMark"> — </span>There is evidence of efficacy in the treatment of somatic symptom disorders with St. John's wort, although the results are limited by short follow-up. In two European randomized double-blind placebo-controlled trials, St. John's wort LI 160 was efficacious in treating patients with somatic symptom disorders (and no coexisting depression) and was well tolerated, although follow-up was limited to six weeks [<a href="#rid38">38,39</a>]. In one study involving 149 patients, more patients improved with St. John's wort compared with placebo (81 versus 50 percent, respectively) [<a href="#rid38">38</a>]. Response rates were also better compared with placebo in another study of 173 patients (45 versus 21 percent, respectively) [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H299916679"><span class="h2">Menopausal symptoms</span><span class="headingEndMark"> — </span>We suggest <strong>not </strong>treating menopause symptoms with St. John's wort. Some evidence suggests that St. John's wort may reduce menopause-related hot flashes. However, methodological weaknesses of available trials make it difficult to draw definitive conclusions. Clinicians should counsel their patients who wish to use St. John's wort as detailed above. (See <a class="local">'Limited evidence of efficacy for most conditions'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>One systematic review of six randomized trials suggests St. John's wort may reduce the frequency and severity of hot flashes when compared to placebo [<a href="#rid40">40-43</a>]. As an example, in one study of 100 women, those randomized to receive St. John's wort extract (standardized to 0.2 percent hypericin) experienced reductions in hot flash frequency, duration, and severity at eight weeks, compared to those who received placebo [<a href="#rid41">41</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trial weaknesses include small sample sizes, incomplete characterization of the herbal product used, and inconsistent assessment of the effectiveness of patient blinding.</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Other conditions</span><span class="headingEndMark"> — </span>For many other conditions tested, there is no evidence of efficacy of treatment with St. John's wort. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Attention deficit/hyperactivity disorder</strong> – In a trial including 54 children and adolescents with attention deficit/hyperactivity disorder, there was no improvement in attention or hyperactivity symptoms with St. John's wort (300 mg three times daily for eight weeks) compared with placebo [<a href="#rid44">44</a>]. Adverse events were similar with St. John's wort or placebo. (See  <a class="medical medical_review" href="/z/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Other alternative therapies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>HIV infection</strong> – In a phase I trial including 30 HIV-infected patients with CD4 counts less than 350 cells/mm<sup>3</sup>, patients received either intravenous (0.25 or 0.5 mg/kg body weight twice weekly or 0.25 mg/kg three times weekly) or oral (0.5 mg/kg daily) hypericin [<a href="#rid45">45</a>]. Treatment was discontinued in over 50 percent of subjects before eight weeks due to moderate or severe phototoxicity; only two patients completed 24 weeks of treatment. There was no demonstrable antiretroviral activity at the doses tested, and furthermore, therapy was considered too toxic.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Smoking cessation</strong> – In one adequately powered placebo-controlled randomized trial evaluating St. John's wort for smoking cessation, abstinence rates were less than 10 percent and not different than placebo [<a href="#rid46">46</a>]. In another randomized controlled placebo-controlled trial, there was no benefit of treatment compared with placebo; however, the study was underpowered and had a high dropout rate [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Irritable bowel syndrome</strong> – In a 12 week trial of St. John's wort (900 mg daily) in 70 patients with irritable bowel syndrome, St. John's wort was less effective than placebo as measured by self-reported bowel symptom score [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H11"><span class="h1">SAFETY</span></p><p class="headingAnchor" id="H12"><span class="h2">Adverse effects</span><span class="headingEndMark"> — </span>A systematic review of clinical trials evaluating St. John's wort found that dropout rates and adverse effects rates in patients receiving St. John's wort were comparable to placebo, lower than tricyclic antidepressants, and slightly lower than selective serotonin reuptake inhibitors (SSRIs) [<a href="#rid9">9,49</a>]. The most common adverse effects included gastrointestinal symptoms, dizziness/confusion, tiredness/sedation, photosensitivity, dry mouth, urinary frequency, anorgasmia, and swelling [<a href="#rid7">7,9</a>].</p><p>Case reports of photosensitivity have been reported in patients taking oral St. John's wort [<a href="#rid45">45,50,51</a>]. These involved a delayed hypersensitivity/photodermatitis following ingestion of herbal tea [<a href="#rid50">50</a>] and reversible photosensitivity after taking 240 mg of hypericum extract daily for three years [<a href="#rid51">51</a>]. Erythematous lesions in light-exposed areas developed but cleared with discontinuation. Limited phototoxicity was seen in a randomized placebo-controlled multiple crossover study of 13 subjects receiving hypericum extract at various doses who were exposed to solar and ultraviolet A (UVA) light before and four hours after drug intake [<a href="#rid52">52</a>]. External use of hypericum extracts have been noted in several anecdotal reports to lead to second degree burns, resulting in scarring, after exposure to direct sunlight [<a href="#rid53">53</a>].</p><p>There is a single case report of supraventricular tachycardia associated with St. John’s wort [<a href="#rid54">54</a>].</p><p>In addition, in an in vitro study, high concentrations of St. John's wort had adverse effects upon oocytes and was mutagenic to sperm cells, leading to concerns that use may lead to decreased fertility [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Contraindicated in pregnancy and lactation</span><span class="headingEndMark"> — </span>The use of St. John's wort should be avoided during pregnancy and lactation since high-quality data demonstrating safety are lacking.</p><p>One small study compared birth outcomes between 54 pregnancies exposed to St. John's wort, 54 exposed to conventional antidepressants, and 54 healthy, non-exposed pregnancies [<a href="#rid56">56</a>]. Major fetal malformations were found in 5.3, 4.3, and 0 percent, respectively, with the rate of fetal malformations in the St. John's wort exposed group not significantly higher than the 3 to 5 percent expected in the general population.</p><p>A German claims-based data analysis compared outcomes for 496 pregnancies exposed to St. John's wort, 420 with exposure during the first trimester [<a href="#rid57">57</a>]. Among the 18 infants born with major malformations, 17 had exposure in the first trimester (relative risk [RR] 3.56, 95% CI 0.48-26.17). Although underpowered and limited by methodologic problems, this finding raises concern over the use of St. John's wort in pregnancy.</p><p>In animal models, uterotonic effects have been reported [<a href="#rid58">58</a>]. In studies of St. John's wort in rodents, methodological weaknesses (including lack of product characterization, inadequate determination of appropriate equivalent human dose, and lack of blinding) preclude any reliable conclusions regarding safety in human pregnancy [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H1330261608"><span class="h2">Discontinue preoperatively</span><span class="headingEndMark"> — </span>In a review of herb use in the perioperative period, it was suggested that, because of the various drug interactions with St. John's wort, it should be discontinued at least five days prior to a planned surgical procedure [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">"Perioperative medication management", section on 'Herbal medications'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">DRUG INTERACTIONS</span><span class="headingEndMark"> — </span>Interactions between St. John's wort and medications are the most common source of adverse effects related to the use of these preparations [<a href="#rid9">9</a>]. Adverse interactions between St. John's wort and certain medications were among the first herb-drug interactions reported [<a href="#rid10">10</a>]. These reports contributed to the growing recognition among clinicians of the potential for adverse herb-drug interactions and the need to ask all patients about nonprescription herb and supplement use. Specific interactions of St. John's wort with other medications may be determined using the <a class="external" href="/drug-interactions">drug interactions program</a> included in UpToDate. This program can be accessed from the UpToDate online search page or through the individual drug information topics in the section on drug interactions.</p><p>Treatment failures with a wide variety of agents including <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a>, antiretrovirals (for the treatment of HIV disease), antifungals, topical beta blockers for glaucoma, immunosuppressive agents for prevention of graft rejection, narcotics, <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">digoxin</a>, and hormonal contraceptives have been associated with the concomitant use of St. John's wort due to significant induction of cytochrome P (CYP) 1A2, 2C19, 2C9, and 3A4, as well as intestinal P-glycoprotein/multidrug efflux pump (MDR)-1 drug transporters [<a href="#rid12">12-22,61-67</a>].</p><p>Use of St. John's wort should be avoided in combination with antidepressants to avoid the potential for the serotonin syndrome [<a href="#rid68">68</a>]. Several cases of serotonin excess (agitation, hyperthermia, diaphoresis, tachycardia, and neuromuscular disturbances including rigidity) have been reported in older adults taking St. John's wort and selective serotonin reuptake inhibitors (SSRIs) together [<a href="#rid69">69</a>].</p><p>Examples of significant interactions between St. John's wort and other medications include:</p><p class="bulletIndent1"><span class="glyph">●</span>There was a report of two cases of acute heart transplant rejection from a reduction in <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">cyclosporine</a> levels due to concomitant St. John's wort [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are case reports of breakthrough bleeding and undesired pregnancy in females taking oral contraceptive pills, presumably due to lowering of ethinylestradiol concentrations [<a href="#rid21">21</a>].</p><p></p><p>Avoidance of foods containing tyramine while taking St. John's wort is unnecessary due to St. John's wort's limited monoamine oxidase (MAO) inhibitory activity [<a href="#rid26">26,70</a>]. However, although St. John's wort is not suggested for the treatment of depression (see <a class="local">'Depression'</a> above), for patients who plan to switch from an SSRI or MAO inhibitor to St. John's wort, there should be a period of drug abstinence; we advise a three- to seven-day wash-out period prior to switching from an SSRI to St. John's wort and a three-week wash-out period prior to switching from an MAO inhibitor to St. John's wort. (See  <a class="medical medical_review" href="/z/d/html/1716.html" rel="external">"Switching antidepressant medications in adults", section on 'Between SSRIs'</a> and  <a class="medical medical_review" href="/z/d/html/1716.html" rel="external">"Switching antidepressant medications in adults", section on 'Switching to or from MAOIs'</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">ADMINISTRATION</span><span class="headingEndMark"> — </span>The majority of studies of St. John's wort utilized extracts standardized to either 0.3% hypericin or 5% hyperforin in a dosage of 300 to 400 mg three times per day [<a href="#rid6">6,7,71,72</a>]. Caution should be employed with long-term use of hypericum extracts due to a lack of studies beyond 8 to 12 weeks.</p><p><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fpharmaceutical-quality-resources%2Fcurrent-good-manufacturing-practice-cgmp-regulations&amp;token=Ach7JNhKnr0%2F33RoaB998ltR7c9mPiead8iSiD6hz7ft7dl%2FDvDJmrPEfdZbzxzXUGL2Gien9jl0%2BC3xgJpBhCIhcuDHKh978rFEQlFuag5K1cDJakGrKLjtQ91IeJXL&amp;TOPIC_ID=1391" target="_blank">Good Manufacturing Practices</a> for the dietary supplement industry have been established by the US Food and Drug Administration (FDA) and were phased in from 2008 to 2010 [<a href="#rid73">73</a>] (see  <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements"</a>). However, no studies have demonstrated a positive impact on product standardization and quality. The resultant uncertainty in the quality of available products is another reason supporting the recommendation against the use of St. John's wort.</p><p>Patients in the United States who choose to use St. John's wort should purchase products that display a seal of approval by one of three independent organizations that offer quality testing: US Pharmacopeia, ConsumerLab.com, and NSF International. Product manufacturers voluntarily submit and pay for their products to be independently evaluated by these organizations for good manufacturing practices, accurate labeling of ingredients, and absence of harmful levels of contaminants. It is important to recognize, however, that a seal of approval does not ensure that a supplement product is effective or safe for all patients.</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Counseling patients</strong> – Patients considering the use of St. John's wort should be counseled and cautioned regarding limited evidence of efficacy, the variability in commercially available products, the lack of regulation in St. John's wort products in the United States, and the potential for herb-drug interactions. Given these limitations, we inform patients that St. John's wort is not an established or well-supported treatment for any indication, including depression and menopause. (See <a class="local">'Limited evidence of efficacy for most conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoid in pregnancy, lactation, and preoperatively</strong> – St. John's wort should not be used during pregnancy or lactation and should be discontinued at least five days preoperatively in patients undergoing a planned surgical procedure. (See <a class="local">'Contraindicated in pregnancy and lactation'</a> above and <a class="local">'Discontinue preoperatively'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Herb-drug interactions</strong> – St. John's wort has the potential for multiple herb-drug interactions through induction of the cytochrome P (CYP) 3A4 and P-glycoprotein systems. Concurrent use of St. John's wort and medications metabolized by these systems should be avoided. Additionally, there have been reports of serotonin syndrome in patients taking St. John's wort concurrently with selective serotonin reuptake inhibitors (SSRI) antidepressants. (See <a class="local">'Drug interactions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lack of standardization</strong> – The variability in quality and contents of available St. John's wort supplements is an additional concern. For patients who choose to use it, they should select products that meet specific quality criteria according to independent laboratory testing. (See <a class="local">'Administration'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hobbs C. St. John's wort--ancient herbal protector. Pharm Hist 1990; 32:166.</a></li><li class="breakAll">Pratt A. Wild Flowers, Society for Promoting Christian Knowledge, London 1853.</li><li class="breakAll">St. John's Wort. In: Lawrence Review of Natural Products, Facts and Comparisons, St. Louis 1997.</li><li><a class="nounderline abstract_t">Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; :1.</a></li><li><a class="nounderline abstract_t">Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; :1.</a></li><li><a class="nounderline abstract_t">Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 2001; 285:1978.</a></li><li><a class="nounderline abstract_t">Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA 2002; 287:1807.</a></li><li><a class="nounderline abstract_t">Fava M, Alpert J, Nierenberg AA, et al. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol 2005; 25:441.</a></li><li><a class="nounderline abstract_t">Knüppel L, Linde K. Adverse effects of St. John's Wort: a systematic review. J Clin Psychiatry 2004; 65:1470.</a></li><li><a class="nounderline abstract_t">Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John's wort. Lancet 2000; 355:547.</a></li><li><a class="nounderline abstract_t">Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort. Lancet 2000; 355:548.</a></li><li><a class="nounderline abstract_t">Johne A, Brockmöller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66:338.</a></li><li><a class="nounderline abstract_t">Sugimoto K, Ohmori M, Tsuruoka S, et al. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001; 70:518.</a></li><li><a class="nounderline abstract_t">Mathijssen RH, Verweij J, de Bruijn P, et al. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94:1247.</a></li><li><a class="nounderline abstract_t">Smith PF, Bullock JM, Booker BM, et al. Induction of imatinib metabolism by hypericum perforatum. Blood 2004; 104:1229.</a></li><li><a class="nounderline abstract_t">Mueller SC, Uehleke B, Woehling H, et al. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 2004; 75:546.</a></li><li><a class="nounderline abstract_t">Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004; 57:592.</a></li><li><a class="nounderline abstract_t">Tannergren C, Engman H, Knutson L, et al. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 2004; 75:298.</a></li><li><a class="nounderline abstract_t">Hebert MF, Park JM, Chen YL, et al. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004; 44:89.</a></li><li><a class="nounderline abstract_t">Eich-Höchli D, Oppliger R, Golay KP, et al. Methadone maintenance treatment and St. John's Wort - a case report. Pharmacopsychiatry 2003; 36:35.</a></li><li><a class="nounderline abstract_t">Mills E, Montori VM, Wu P, et al. Interaction of St John's wort with conventional drugs: systematic review of clinical trials. BMJ 2004; 329:27.</a></li><li><a class="nounderline abstract_t">Nieminen TH, Hagelberg NM, Saari TI, et al. St John's wort greatly reduces the concentrations of oral oxycodone. Eur J Pain 2010; 14:854.</a></li><li><a class="nounderline abstract_t">Bennett DA Jr, Phun L, Polk JF, et al. Neuropharmacology of St. John's Wort (Hypericum). Ann Pharmacother 1998; 32:1201.</a></li><li><a class="nounderline abstract_t">Müller WE, Singer A, Wonnemann M, et al. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998; 31 Suppl 1:16.</a></li><li><a class="nounderline abstract_t">Singer A, Wonnemann M, Müller WE. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharmacol Exp Ther 1999; 290:1363.</a></li><li><a class="nounderline abstract_t">Thiede HM, Walper A. Inhibition of MAO and COMT by hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1:S54.</a></li><li><a class="nounderline abstract_t">Perovic S, Müller WE. Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung 1995; 45:1145.</a></li><li><a class="nounderline abstract_t">Müller WE, Rossol R. Effects of hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1:S63.</a></li><li><a class="nounderline abstract_t">Thiele B, Brink I, Ploch M. Modulation of cytokine expression by hypericum extract. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1:S60.</a></li><li><a class="nounderline abstract_t">Muller WE, Schafer C. Johanniskraut: in-vitro Studie uber Hypericum-Extrakt, Hypericin und Kampferol. Deutsche Apotheker Zeitung 1996; 136:1015.</a></li><li><a class="nounderline abstract_t">Lopez-Bazzocchi I, Hudson JB, Towers GH. Antiviral activity of the photoactive plant pigment hypericin. Photochem Photobiol 1991; 54:95.</a></li><li><a class="nounderline abstract_t">Wood S, Huffman J, Weber N, et al. Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives. Planta Medica 1990; 56:651.</a></li><li><a class="nounderline abstract_t">Carpenter S, Kraus GA. Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem Photobiol 1991; 53:169.</a></li><li><a class="nounderline abstract_t">Jesionek W, Móricz ÁM, Alberti Á, et al. TLC-Direct Bioautography as a Bioassay Guided Method for Investigation of Antibacterial Compounds in Hypericum perforatum L. J AOAC Int 2015; 98:1013.</a></li><li><a class="nounderline abstract_t">Gerstel J, Turner T, Ruiz G, et al. Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections. Phytother Res 2018; 32:2577.</a></li><li><a class="nounderline abstract_t">Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev 2008; :CD000448.</a></li><li><a class="nounderline abstract_t">Rapaport MH, Nierenberg AA, Howland R, et al. The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res 2011; 45:931.</a></li><li><a class="nounderline abstract_t">Müller T, Mannel M, Murck H, Rahlfs VW. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. Psychosom Med 2004; 66:538.</a></li><li><a class="nounderline abstract_t">Volz HP, Murck H, Kasper S, Möller HJ. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology (Berl) 2002; 164:294.</a></li><li><a class="nounderline abstract_t">Al-Akoum M, Maunsell E, Verreault R, et al. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial. Menopause 2009; 16:307.</a></li><li><a class="nounderline abstract_t">Abdali K, Khajehei M, Tabatabaee HR. Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study. Menopause 2010; 17:326.</a></li><li><a class="nounderline abstract_t">Eatemadnia A, Ansari S, Abedi P, Najar S. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial. Complement Ther Med 2019; 45:109.</a></li><li><a class="nounderline abstract_t">Liu YR, Jiang YL, Huang RQ, et al. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety. Climacteric 2014; 17:325.</a></li><li><a class="nounderline abstract_t">Weber W, Vander Stoep A, McCarty RL, et al. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA 2008; 299:2633.</a></li><li><a class="nounderline abstract_t">Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med 1999; 130:510.</a></li><li><a class="nounderline abstract_t">Parsons A, Ingram J, Inglis J, et al. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation. Drug Alcohol Depend 2009; 102:116.</a></li><li><a class="nounderline abstract_t">Sood A, Ebbert JO, Prasad K, et al. A randomized clinical trial of St. John's wort for smoking cessation. J Altern Complement Med 2010; 16:761.</a></li><li><a class="nounderline abstract_t">Saito YA, Rey E, Almazar-Elder AE, et al. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol 2010; 105:170.</a></li><li><a class="nounderline abstract_t">Kasper S, Gastpar M, Möller HJ, et al. Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol 2010; 25:204.</a></li><li class="breakAll">Newall CA, Anderson LA, Phillipson JD. Herbal medicines: A guide for health-care professionals, The Pharmaceutical Press, London 1996.</li><li><a class="nounderline abstract_t">Golsch S, Vocks E, Rakoski J, et al. [Reversible increase in photosensitivity to UV-B caused by St. John's wort extract]. Hautarzt 1997; 48:249.</a></li><li><a class="nounderline abstract_t">Brockmöller J, Reum T, Bauer S, et al. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 1997; 30 Suppl 2:94.</a></li><li class="breakAll">Upton, R (ed). American Herbal Pharmacopoeia and Therapeutic Compendium. St. John's Wort Hypericum perforatum 1997.</li><li><a class="nounderline abstract_t">Fisher KA, Patel P, Abualula S, Concepion L. St. John's Wort-Induced Supraventricular Tachycardia. Cureus 2021; 13:e14356.</a></li><li><a class="nounderline abstract_t">Ondrizek RR, Chan PJ, Patton WC, King A. An alternative medicine study of herbal effects on the penetration of zona-free hamster oocytes and the integrity of sperm deoxyribonucleic acid. Fertil Steril 1999; 71:517.</a></li><li><a class="nounderline abstract_t">Moretti ME, Maxson A, Hanna F, Koren G. Evaluating the safety of St. John's Wort in human pregnancy. Reprod Toxicol 2009; 28:96.</a></li><li><a class="nounderline abstract_t">Schäfer W, Wentzell N, Schink T, Haug U. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis. Reprod Toxicol 2021; 102:90.</a></li><li><a class="nounderline abstract_t">Kŭnchev K, Liutskanov D, Arsenov L. [Comparative studies of plans for controlling American foulbrood in public aviaries]. Vet Med Nauki 1981; 18:94.</a></li><li><a class="nounderline abstract_t">Avila C, Whitten D, Evans S. The safety of St John's wort (Hypericum perforatum) in pregnancy and lactation: A systematic review of rodent studies. Phytother Res 2018; 32:1488.</a></li><li><a class="nounderline abstract_t">Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208.</a></li><li><a class="nounderline abstract_t">Gordon RY, Becker DJ, Rader DJ. Reduced efficacy of rosuvastatin by St. John's Wort. Am J Med 2009; 122:e1.</a></li><li><a class="nounderline abstract_t">Ernst E. Second thoughts about safety of St John's wort. Lancet 1999; 354:2014.</a></li><li><a class="nounderline abstract_t">Moore LB, Goodwin B, Jones SA, et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 2000; 97:7500.</a></li><li><a class="nounderline abstract_t">Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290:1500.</a></li><li><a class="nounderline abstract_t">Mannel M. Drug interactions with St John's wort : mechanisms and clinical implications. Drug Saf 2004; 27:773.</a></li><li><a class="nounderline abstract_t">Mueller SC, Majcher-Peszynska J, Uehleke B, et al. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 2006; 62:29.</a></li><li><a class="nounderline abstract_t">Edington M, Siempis T, Montgomery D. Discontinuation of the herbal preparation Hypericum perforatum, also known as St John's wort, associated with improved intraocular pressure control in a patient on topical beta-blockers for primary open-angle glaucoma. Oman J Ophthalmol 2018; 11:188.</a></li><li><a class="nounderline abstract_t">Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998; 55:1033.</a></li><li><a class="nounderline abstract_t">Lantz MS, Buchalter E, Giambanco V. St. John's wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 1999; 12:7.</a></li><li><a class="nounderline abstract_t">Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of hypericum extract. J Geriatr Psychiatry Neurol 1994; 7 Suppl 1:S57.</a></li><li><a class="nounderline abstract_t">Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression--an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313:253.</a></li><li class="breakAll">Treatment of Depression–Newer Pharmacotherapies. Summary, Evidence Report/Technology Assessment: Number 7, March 1999. Agency for Health Care Policy and Research, Rockville, MD. Available at: www.ahcpr.gov/clinic/epcsums/deprsumm.htm (Accessed on August 08, 2005).</li><li class="breakAll">www.fda.gov/bbs/topics/NEWS/2007/NEW01657.html (Accessed on October 09, 2007).</li></ol></div><div id="topicVersionRevision">Topic 1391 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11622735" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : St. John's wort--ancient herbal protector.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11622735" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : St. John's wort--ancient herbal protector.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11622735" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : St. John's wort--ancient herbal protector.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15188733" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Complementary and alternative medicine use among adults: United States, 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19361005" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Complementary and alternative medicine use among adults and children: United States, 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11308434" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Effectiveness of St John's wort in major depression: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11939866" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16160619" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15554758" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Adverse effects of St. John's Wort: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10683007" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Indinavir concentrations and St John's wort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10683008" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acute heart transplant rejection due to Saint John's wort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10546917" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11753267" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12189228" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Effects of St. John's wort on irinotecan metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15294859" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Induction of imatinib metabolism by hypericum perforatum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15179409" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15089812" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15060508" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14681346" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12649774" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Methadone maintenance treatment and St. John's Wort - a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15231618" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Interaction of St John's wort with conventional drugs: systematic review of clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20106684" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : St John's wort greatly reduces the concentrations of oral oxycodone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9825087" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Neuropharmacology of St. John's Wort (Hypericum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9684943" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10454515" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7857510" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Inhibition of MAO and COMT by hypericum extracts and hypericin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8929227" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7857514" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effects of hypericum extract on the expression of serotonin receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7857513" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Modulation of cytokine expression by hypericum extract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Johanniskraut: in-vitro Studie uber Hypericum-Extrakt, Hypericin und Kampferol</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1658826" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Antiviral activity of the photoactive plant pigment hypericin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1707176" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Photosensitization is required for inactivation of equine infectious anemia virus by hypericin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26268984" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : TLC-Direct Bioautography as a Bioassay Guided Method for Investigation of Antibacterial Compounds in Hypericum perforatum L.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30251279" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18843608" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : St John's wort for major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21632064" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15272100" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12424553" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19194342" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20216274" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31331546" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24188229" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18544723" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10075619" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19328636" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20590478" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A randomized clinical trial of St. John's wort for smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19809408" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20568656" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20568656" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9206713" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : [Reversible increase in photosensitivity to UV-B caused by St. John's wort extract].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9342768" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9342768" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33972911" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : St. John's Wort-Induced Supraventricular Tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10065791" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : An alternative medicine study of herbal effects on the penetration of zona-free hamster oocytes and the integrity of sperm deoxyribonucleic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19491000" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Evaluating the safety of St. John's Wort in human pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33961968" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7340114" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : [Comparative studies of plans for controlling American foulbrood in public aviaries].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29708295" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The safety of St John's wort (Hypericum perforatum) in pregnancy and lactation: A systematic review of rodent studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11448284" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Herbal medicines and perioperative care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19185075" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Reduced efficacy of rosuvastatin by St. John's Wort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10636361" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Second thoughts about safety of St John's wort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10852961" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13129991" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15350151" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Drug interactions with St John's wort : mechanisms and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16341856" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29930462" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Discontinuation of the herbal preparation Hypericum perforatum, also known as St John's wort, associated with improved intraocular pressure control in a patient on topical beta-blockers for primary open-angle glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9819073" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Herbal remedies in psychiatric practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10447148" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : St. John's wort and antidepressant drug interactions in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7857511" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Inhibition of MAO by fractions and constituents of hypericum extract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8704532" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : St John's wort for depression--an overview and meta-analysis of randomised clinical trials.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
